EP2964202
Samsetningar af deferasírox til notkunar um munn
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
6.3.2014EP published:
31.10.2018EP application number:
14710654.6
EP translation filed:
28.1.2019Grant published:
15.2.2019EPO information:
European Patent Register
Max expiry date:
5.3.2034Expiry date:
5.3.2024
Title:
ORAL FORMULATIONS OF DEFERASIROX
Timeline
Today
6.3.2014EP application
31.10.2018EP Publication
28.1.2019Translation submitted
15.2.2019Registration published
5.3.2024Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056, Basel, CH
Inventor
Name:
GHOSH, IndrajitAddress:
East Hanover, New Jersey, US
Name:
ZHANG, Jia-AiAddress:
East Hanover, New Jersey, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201361774893 PDate:
8.3.2013Country:
US
Number:
201361824435 PDate:
17.5.2013Country:
US
Classification
Categories:
A61K 9/20, A61K 9/28, A61K 9/50, A61K 31/4196, A61P 39/04
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 1.3.2019
Expires: 5.3.2020
Payer: Árnason Faktor
Number: 7
Paid: 24.2.2020
Expires: 5.3.2021
Payer: Árnason Faktor ehf.
Number: 8
Paid: 28.2.2021
Expires: 5.3.2022
Payer: Árnason Faktor ehf.
Number: 9
Paid: 24.2.2022
Expires: 5.3.2023
Payer: Árnason Faktor ehf.
Number: 10
Paid: 26.2.2023
Expires: 5.3.2024
Payer: Árnason Faktor ehf.